310210.KQ
Voronoi, Inc.
KOE · Healthcare · Biotechnology · RO
KRW 147,200.00
−13.16%Year over year
Reported trailing growth
- Revenue
- +24.2%
- EBITDA
- -90.8%
- EBIT
- -81.2%
- EPS
- -67.6%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.4%
- EBITDA
- -53.0%
- EBIT
- -60.1%
- Net income
- -47.2%
- EPS
- -40.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026